Posted by Journal Watch Editors on November 13th, 2009
Investigators have suspected that there isn’t much advantage to renovascular angioplasty and stenting in atherosclerosis, but their studies haven’t had the statistical power to prove that point. A new bit of research in this week’s New England Journal of Medicine may have hit the mark. We’ve got an interview with two of the principals of the ASTRAL study (that’s their acronym for Angioplasty and Stenting for Renal Artery Lesions). Dr. Philip Kalra, the nephrology lead, and Dr. Jonathan Moss, the radiology lead, kindly agreed to the conversation, which I think you’ll find of interest.
Reach us with your comments and suggestions at jelia@jwatch.org, or call 1-617-440-4374.
This edition’s links:
Interview link–
News links–
Posted by Journal Watch Editors on November 12th, 2009
Avoiding use of the heart-lung machine during coronary artery bypass grafting was supposed to lower neurocognitive problems and other complications after the procedure. A large randomized trial finds otherwise. We’ve got a conversation with one of the investigators, Frederick Grover.
To contact us, call 1-617-440-4374. You can write to me at jelia@jwatch.org.
This week’s links:
News links:
Interview links:
Posted by Journal Watch Editors on November 2nd, 2009
There are consequences of even short-term use of some drugs. Take the second-generation antipsychotics. A 3-month course can cause weight gain of almost 20 pounds in young people, according to a JAMA study. We interview Dr. Christoph Correll about the implications.
To reach Clinical Conversations, you can call 1-617-440-4374 or email me at jelia@jwatch.org.
This weeks news and interview links:
News:
Interview: